Warashina A
Department of Physiology, Niigata University School of Medicine, Asahimachi-dori, Niigata,
Biol Signals Recept. 1998 Nov-Dec;7(6):307-20. doi: 10.1159/000014554.
Modulatory effects of the activation of either protein kinase C (PKC) by phorbol 12,13-dibutyrate (PDBu) or protein kinase A (PKA) by forskolin on stimulant-evoked secretory processes in the perfused rat adrenal medulla were studied. PDBu or forskolin was applied during repetitive stimulation (30 s each at 10-min intervals) with nicotine, bradykinin, muscarine or histamine, and changes in [Ca2+]i (fura-2 microfluorometry) and catecholamine secretions (electrochemical detection) were simultaneously measured. PDBu markedly potentiated the nicotine-evoked secretion without altering the [Ca2+]i response. PDBu partially inhibited the muscarine-evoked secretion and almost completely blocked the histamine-evoked secretion, concomitantly with extensive suppressions of the [Ca2+]i responses to these stimulants. The bradykinin-evoked secretion was enhanced by PDBu despite a slight attenuation of the [Ca2+]i response. PDBu reduced bradykinin-induced intracellular Ca2+ release in a Ca2+-free medium but enhanced the secretion associated with the released Ca2+. These results suggest that PDBu-activated PKC modulates secretory processes at, at least, two different stages. An early-stage modulation may downregulate receptor/G protein systems, which accounts for the inhibitory effect of PDBu on the muscarine- and histamine-evoked responses. A late-stage modulation may generally promote Ca2+-triggered exocytosis after elevation of [Ca2+]i, which explains the potentiation of the nicotine-evoked secretion by PDBu. The late-stage modulation may counteract the early-stage modulation in bradykinin-stimulated cells. Forskolin potentiated the secretory responses to the four secretagogues without increasing the [Ca2+]i responses. PKA may modulate secretory process at a step(s) distal to the rise in [Ca2+]i as is the case with the late-stage modulation by PKC.
研究了佛波醇12,13 - 二丁酸酯(PDBu)激活蛋白激酶C(PKC)或福斯高林激活蛋白激酶A(PKA)对灌注大鼠肾上腺髓质中刺激诱发分泌过程的调节作用。在使用尼古丁、缓激肽、毒蕈碱或组胺进行重复刺激(每隔10分钟刺激30秒)期间应用PDBu或福斯高林,并同时测量[Ca2+]i(fura - 2显微荧光测定法)和儿茶酚胺分泌(电化学检测)的变化。PDBu显著增强尼古丁诱发的分泌,而不改变[Ca2+]i反应。PDBu部分抑制毒蕈碱诱发的分泌,并几乎完全阻断组胺诱发的分泌,同时伴随着对这些刺激物的[Ca2+]i反应的广泛抑制。尽管[Ca2+]i反应略有减弱,但PDBu增强了缓激肽诱发的分泌。在无钙培养基中,PDBu减少缓激肽诱导的细胞内Ca2+释放,但增强与释放的Ca2+相关的分泌。这些结果表明,PDBu激活的PKC至少在两个不同阶段调节分泌过程。早期调节可能下调受体/G蛋白系统,这解释了PDBu对毒蕈碱和组胺诱发反应的抑制作用。晚期调节可能在[Ca2+]i升高后普遍促进Ca2+触发的胞吐作用,这解释了PDBu对尼古丁诱发分泌的增强作用。在缓激肽刺激的细胞中,晚期调节可能抵消早期调节。福斯高林增强了对四种促分泌剂的分泌反应,而不增加[Ca2+]i反应。PKA可能在[Ca2+]i升高的远端步骤调节分泌过程,就像PKC的晚期调节一样。